The potential of ribozymes as antiviral agents. (Q40466955)

20 September 2017

1 reference

title

The potential of ribozymes as antiviral agents. (English)

1 reference

20 September 2017

0 references

Sczakiel G

1

1 reference

PubMed ID

7648028

20 September 2017

Nedbal W

series ordinal

2

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

Trends in Microbiology

1 reference

20 September 2017

3

1 reference

20 September 2017

213-217

1 reference

20 September 2017

6

1 reference

Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

1 reference

7 January 2021

A small catalytic oligoribonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Simple RNA enzymes with new and highly specific endoribonuclease activities

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Cleavage of specific sites of RNA by designed ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

The potential use of catalytic RNAs in therapy of HIV infection and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

RNA enzymes as tools for gene ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Inhibition of gene expression with ribozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Ribozymes as potential anti-HIV-1 therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre-mRNA processing in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

What makes an mRNA anti-sense-itive?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

A kinetic and thermodynamic framework for the hammerhead ribozyme reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Design and specificity of hammerhead ribozymes against calretinin mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Attenuation of white gene expression in transgenic Drosophila melanogaster: possible role of a catalytic antisense RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Antisense RNA control in bacteria, phages, and plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Control of ColE1 plasmid replication. Intermediates in the binding of RNA I and RNA II

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

RNA annealing activities in HeLa nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Protein enhancement of hammerhead ribozyme catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

Gene therapy. Intracellular immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2988927-1

7 January 2021

10.1016/S0966-842X(00)88927-1

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7648028